StockNews.com began coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research report released on Saturday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock.
Athersys Stock Performance
Athersys has a 52-week low of $0.01 and a 52-week high of $1.99. The stock has a market capitalization of $833,000.00, a price-to-earnings ratio of -0.01 and a beta of -0.90.
Athersys Company Profile
Featured Stories
- Five stocks we like better than Athersys
- How to buy stock: A step-by-step guide for beginners
- How to Master Trading Discipline: Overcome Emotional Challenges
- Why Invest in 5G? How to Invest in 5G Stocks
- Trump Tax Reforms: 7 Stocks That Could Benefit in 2025
- Stock Market Sectors: What Are They and How Many Are There?
- 3 Stocks Near 52-Week Lows: Why They Could Be Smart Buys Today
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.
